RTC
FATE icon

Riverview Trust Company’s Fate Therapeutics FATE Stock Holding History

Riverview Trust Company’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,497
Closed -$14.2K – 700
2023
Q1 		$14.2K Buy
+2,497
New +$14.2K 0.01% 511